FDA Warns Drugmakers of Additional Cancer Risks Associated with CAR T-Cell Therapy

1 min read

New FDA guidelines require manufacturers to add boxed warnings to CAR T-cell therapy products.

You May Also Like

More From Author

+ There are no comments

Add yours